您的当前位置:
首页 >
研究报告 >
公司调研 > 预览报告
{{Name}}
公司法人:{{CEO}}
成立日期:{{BirthDate}}
管理规模:{{Scale}}
管理产品:{{ProdCount}}只
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5899360","PageTitle":"华仁药业:年报符合预期 腹膜透析液项目前景可观-公司调研 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":97,"Face":"/_files/face/0/t0p3qgmu.jpg","UName":"戚雅容","UpArts":0,"UpRpts":23363,"UpLbies":33},"Rid":5899360,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/公司调研/20110308-南京证券-华仁药业-300110.SZ-华仁药业年报符合预期腹膜透析液项目前景可观.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}